Anagrelide treatment and cardiovascular monitoring in essential thrombocythemia. A prospective observational study

Author:

Tortorella Giovanni,Piccin Andrea,Tieghi Alessia,Marcheselli Luigi,Steurer Michael,Gastl Günther,Codeluppi Katia,Fama Angelo,Santoro Umberto,Birtolo Chiara,Gugliotta Gabriele,Cortelazzo Sergio,Gugliotta Luigi

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference33 articles.

1. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms;Tefferi;Leukemia,2008

2. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia;Cortelazzo;J Clin Oncol,1990

3. Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation;Barbui;Haematologica,2004

4. Risk factors for thrombosis and bleeding and their influence on therapeutic decisions in patients with essential thrombocythemia;Griesshammer;Semin Thromb Hemost,2006

5. Guideline for investigation and management of adults and children presenting with a thrombocytosis;Harrison;Br J Haematol,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3